Resveratrol: Potential as anticancer agent

Journal of Dietary Supplements

Volumn 9, Issue 1, 2012, Pages 45-56

  Aluyen, Julia Khristine ^a   Ton, Quynhanh N ^a   Tran, Thuytram ^a   Yang, Alice E ^a   Gottlieb, Helmut B ^a   Bellanger, Renee A ^a  

^a UNIVERSITY OF THE INCARNATE WORD   (United States)

Author keywords

Anticancer; Cancer; Phytolexin; Resveratrol

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; PLANT EXTRACT; RESVERATROL; STILBENE DERIVATIVE;

APOPTOSIS; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; HUMAN; NEOPLASM; OUTCOME ASSESSMENT; PHYTOTHERAPY; POLYGONUM CUSPIDATUM; REVIEW; VITIS; WINE;

ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL PROLIFERATION; HUMANS; NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PHYTOTHERAPY; PLANT EXTRACTS; POLYGONUM CUSPIDATUM; STILBENES; VITIS; WINE;

EID: 84857383033     PISSN: 19390211     EISSN: 1939022X     Source Type: Journal    
DOI: 10.3109/19390211.2011.650842     Document Type: Review

References (17)

1. Banerjee S, LastBueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthraceneinduced mammary carcinogenesis in rats by resveratrol: Role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 2002;62(17). Retrieved from http://www.ncbi.nlm. nih.gov/pubmed/12208745
2. Bishayee A, Dhir N. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: Inhibition of cell proliferation and induction of apoptosis. Chem Biol Interact. 2009;179(2-3):131-144.
3. Boocock D, Faust G, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007;16(6). Retrieved from http://cebp.aacrjournals.org/content/16/6/1245.long
4. Carbó N, Costelli P, Baccino FM, López-Soriano FJ, Argilés JM. Resveratrol, a natural product present in wine, decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun. 1999;254(3). Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9920811
5. CBS News. Fountain of youth in a wine rx? (Producers: DN Curran and K Texton; Reporter: M Safer; aired 25 January 2009). Retrieved January 17, 2012, from http://www.cbsnews.com/stories/2009/01/25/60minutes/main4752082.shtml
6. Ferrieres J. The french paradox: Lessons for other countries. Heart. 2004;90(107). Retrieved from http://heart.bmj.com/content/90/1/107.extract
7. Golkar L, Ding XZ, Ujiki MB, Salabat MR, Kelly DL, Scholtens D, Fought AJ, Bentrem DJ, Talamonti MS, Bell RH, Adrian TE. Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res. 2007;138(2). Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17257620
8. Hwang JT, Kwak DW, Lin SK, Kim HM, Kim YM, Park OJ. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of ampk signaling pathway. Ann NY Acad Sci. 2007;1095. Retrieved from http://www.ncbi.nlm.nih.gov/ pubmed/17404056
9. Therapeutic Research Faculty. Natural medicines comprehensive database (12th ed.). 2010. Retrieved March 2010, from http://www.accesspharmacy.com/ herbs.aspx?herbs=1&index=R la
10. Porte C, Voduc N, Zhang G, Seguin I, Tardiff D, Singhal N, Cameron DW. Steady-state pharmacokinetics and tolerability of trans-resveratrol 2000mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet. 2010;49(7):449-454.
11. Pervaiz S. Resveratrol: From grapevines to mammalian biology. FASEB J. 2003;17. Retrieved from http://www.fasebj.org/cgi/content/full/17/14/1975
12. Sengottuvelan M, Deeptha K, Nalini N. Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazine-induced colon carcinogenesis. Nutrition. 2009;25(11-12). Retrieved from http://www.ncbi.nlm. nih.gov/pubmed/19818280
13. Sexton E, van Themsche C, Leblanc K. Resveratrol interferes with akt activity and triggers apoptosis in human uterine cancer cells. Mol Cancer 2006;45(5), doi: 10.1186/1476-4598-5-45. Retrieved from http://www.ncbi.nlm.nih. gov/pmc/articles/PMC1626081/?tool=pubmed
14. Su JL, Yang CY, Zhao M, Kuo ML, Yen ML. Forkhead proteins are critical for bone morphogenetic protein-2 regulation and anti-tumor activity of resveratrol. J Biol Chem. 2007;282(27). Retrieved from http://www.jbc.org/ content/282/27/19385.abstract
15. Sun C, Hu Y, Liu X,Wu T,Wang Y, HeW,Wei W. Resveratrol downregulates the constitutional activation of nuclear factor-?B in multiple myeloma cells, leading to suppression of proliferation and invasion, arrest of cell cycle, and induction of apoptosis. Cancer Genet Cytogen. 2006;165(1). Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16490592
16. Tang FY, Chiang EPI, Sun YC. Resveratrol inhibits heregulin-ß1- mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. J Nutr Biochem. 2008;19(5). Retrieved from http://www.jnutbio. com/article/S0955-2863%2807% 2900114-3/abstract
17. Teskac K, Kristl J. The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm. 2010;390:61-69.